Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep 16:13:1030874.
doi: 10.3389/fmicb.2022.1030874. eCollection 2022.

Editorial: Antimicrobial peptides and mRNA therapy: Clinical, Veterinary, and plant pathology perspectives with special attention to combatting MDR pathogens

András Fodor  1   2 , Orsolya Méhi  3 , Maurizio Brivio  4
Affiliations
Editorial

Editorial: Antimicrobial peptides and mRNA therapy: Clinical, Veterinary, and plant pathology perspectives with special attention to combatting MDR pathogens

András Fodor et al. Front Microbiol. .
No abstract available

Keywords: AMP-encoding mRNA; antimicrobial nucleic acid therapy; antimicrobial peptide (AMP); in vitro transcribed; in vivo translated AMP-encoding mRNA; multidrug resistance (MDR); panresistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Antimicrobial peptides and mRNA therapy: Clinical, Veterinary and plant pathology perspectives with special attention to combatting MDR pathogens

References

    1. Fodor A., Abate B. A., Deák P., Fodor L., Gyenge E., Klein M. G., et al. . (2020). Multidrug Resistance (MDR) and collateral sensitivity in bacteria, with special attention to genetic and evolutionary aspects and the perspectives of antimicrobial peptides-a review. Pathogens 9, 522. 10.3390/pathogens9070522 - DOI - PMC - PubMed
    1. Fodor A., Clarke D. J., Dillman A. R., Tarasco E., Hazir S. (2022). Editorial: new antimicrobial peptides from bacteria/invertebrate obligate symbiotic associations. Front. Microbiol. 13, 862198. 10.3389/fmicb.2022.862198 - DOI - PMC - PubMed
    1. Karikó K., Whitehead K., van der Meel R. (2021). What does the success of mRNA vaccines tell us about the future of biological therapeutics? Cell Syst. 12, 757–758. 10.1016/j.cels.2021.07.005 - DOI - PMC - PubMed
    1. Lázár V., Martins A., Spohn R., Daruka L., Grézal G., Fekete G., et al. . (2018). Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat. Microbiol. 3, 718–731. 10.1038/s41564-018-0164-0 - DOI - PMC - PubMed
    1. Ötvös L., Jr., Wade J. D. (2014). Current challenges in peptide-based drug discovery. Front. Chem. 2, 62. 10.3389/fchem.2014.00062 - DOI - PMC - PubMed

Publication types

LinkOut - more resources